4.6 Review

Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?

期刊

CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 107, 期 4, 页码 780-785

出版社

WILEY
DOI: 10.1002/cpt.1795

关键词

-

资金

  1. National Institutes of Health (NIH) [P30 CA118100, U24 CA224370, U01 CA239108, U24 TR002278]

向作者/读者索取更多资源

As the field of artificial intelligence and machine learning (AI/ML) for drug discovery is rapidly advancing, we address the question What is the impact of recent AI/ML trends in the area of Clinical Pharmacology? We address difficulties and AI/ML developments for target identification, their use in generative chemistry for small molecule drug discovery, and the potential role of AI/ML in clinical trial outcome evaluation. We briefly discuss current trends in the use of AI/ML in health care and the impact of AI/ML context of the daily practice of clinical pharmacologists.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据